Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives
Status:
Active, not recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is an ongoing randomized clinical trial
in 25,875 US men and women investigating whether taking dietary supplements of vitamin D3
(2000 IU) or omega-3 fatty acids (Omacor (R) fish oil, 1 gram) reduces the risk of developing
cancer, heart disease, and stroke in people who do not have a prior history of these
illnesses. The VITAL Kidney Function in Hypertension ancillary study will evaluate the
effects of vitamin D or omega-3 fatty acids on kidney function among participants with
baseline hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Albert Einstein College of Medicine Albert Einstein College of Medicine of Yeshiva University
Collaborators:
Brigham and Women's Hospital National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins